On the decline - Avis employé Employé (anonyme) Merck

3,0
14 déc. 2018
Employé (anonyme)
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Easy job. Nice benefits. Good salary if you're not living in an expensive area.

Inconvénients

No opportunities for career advancement. Merck was actively trying to get right of more seasoned sales reps so they could hire fresh college graduates so they could pay them less. Overall, if you're starting your career, stay away from Merck or any pharma company. There's no future in pharma sales. Merck has the most ridiculous year end performance reviews ever. You get stacked ranked no matter how well you did. Some people had great sales numbers but poor rankings because their manager didn't like them. Overall, a lot of politics involved with the reviews. If you like to play the game, Merck is the company for you. Merck is a very conservative company. Their policy and procedures will drive you crazy. Stay away if you want to grow your career or want any kind of job security. You're not going to get it at Merck.

Découvrez plus d’avis sur Merck

5,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Excellent company to work with.

Inconvénients

No cons encountered so far

4,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Inconvénients

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Voir les avis par: Utile|Évaluation|Date|Tout